The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Intelgenx Technologies Corp

Venture: IGX
Delayed quote

$0.69

Today's change+0.04 +6.15%
Updated July 22 3:59 PM EDT. Delayed by at least 15 minutes.
 

Intelgenx Technologies Corp

Venture: IGX
Delayed quote

$0.69

Today's change+0.04 +6.15%
Updated July 22 3:59 PM EDT. Delayed by at least 15 minutes.

Intelgenx Technologies Corp crosses above 20-day moving average

Intelgenx Technologies Corp closed up sharply Friday, rallying $0.04 or 6.15% to $0.69 and crossing above its 20-day moving average. Over the last five days, shares have gained 9.52%, but are currently unchanged over the last year to date. Shares have underperformed the S&P TSX by 12.44% during the last year.

Key company metrics

  • Trailing P/E58.77×
  • P/E 1 year forward17.25×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.01
Updated July 22 3:59 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.31%

Based on its net profit margin of 11.31%, Intelgenx Technologies Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.24%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue1221
Total other revenue--------
Total revenue1221
Gross profit--------
Total cost of revenue--------
Total operating expense2111
Selling / general / administrative1111
Research & development0000
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income-1010
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-1010
Income after tax-1010
Income tax, total--0----
Net income-1010
Total adjustments to net income--------
Net income before extra. items-1010
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1010
Inc. avail. to common incl. extra. items-1010
Diluted net income-1010
Dilution adjustment----0--
Diluted weighted average shares64686464
Diluted EPS excluding extraordinary itemsvalue per share-0.010.000.020.00
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.010.000.020.00